If you are concerned about that there may well be an opportunity to buy on market an favourable prices.
Disc: ex holder
Printable View
Somebody predicted a cash issue of 1 for 3 at 10 cents. Damn near got it right, if you give or take 25 cents.
Hmmmm
16500 x 780 = 12 870 000 USD
May take some more years to turn up on the cash flow.
I find this interesting,
National Pricing for CMS
On the 12th of October 2018, the Company announced that the preliminary national CMS
reimbursement rate of US$760 per Cxbladder test had been publicly notified. This pricing
was finalised during November 2018 and takes effect from 1 January 2019. Obtaining the
pricing is the second of three steps to enable the Company to be reimbursed by CMS for
Cxbladder tests performed for CMS patients. The third and final step is the inclusion of
Cxbladder in the Local Coverage Determination (LCD) which the Company continues to
work towards achieving.
Bring on LCD,
Maybe some back pay is due.
share price rock solid ish, SPP getting a good deal at 35c they say
No worries raising $7m either
Nice long lag until the SPP, so hopefully some "good News" before the end of January. I think that there is about $10 million of unpaid tests waiting for LCD. I am pleasantly surprised at how well this cash issues has gone, although it only buys them another 6 months at this stage.
Stunning!
Driver goes off the road* big time and lands the car in the ditch - several times. (* driver could be drunk on two occasions)
Car has had to be craned out from the ditch and put back on the road with new tyres and after panel beaten back to shape - several times.
This time, the driver drove the car (again) into the ditch but it is all good as the dents are not as big and the damage is confined to the front tyres being replaced.
And he is not drunk while driving!
The driver should be congratulated?
Humbug! Big fat Danish porkie sausage!